Key result
One year adherence to weight transmissions using the e-Vita HF telemonitoring platform was 74%, with adherent patients having fewer prior heart failure hospitalizations (8% vs. 23%, p=0.021).
Why the study?
Research on the use of and adherence to home telemonitoring data can provide new insights into telemonitoring for daily management of patients with HF.
What are the patterns of use and adherence to a heart failure telemonitoring platform in stable HF patients?
Observational (n=150)
Yes
What are the patterns of use and adherence to a heart failure telemonitoring platform in stable HF patients?
Adherence to remote patient monitoring in stable heart failure patients is high initially but decreases over time, with prior HF hospitalization inversely associated with adherence.
Adherence patterns support feasibility of telemonitoring in select stable HF patients; leaves open outcome benefits and optimal targeting.
BACKGROUND Research of use and adherence to home telemonitoring data can provide new insights into telemonitoring for daily management of patients with heart failure (HF). OBJECTIVE We described the use of a telemonitoring platform, including remote patient monitoring (RPM) of blood pressure, pulse, and weight, and the use of the electronic personal health record (PHR). Patient characteristics were assessed in both adherent and non-adherent patients to weight transmissions. METHODS A post-hoc analysis of the e-Vita HF trial, a three-arm parallel-randomized trial performed in stable HF patients managed in outpatient clinics in the Netherlands. In this study, data were analysed of the participants in the intervention arm (e-Vita HF platform). Adherence to weight transmissions was defined as ≥ 3 times/week for at least 42 weeks during a year. RESULTS Data of 150 patients (mean age 67 ± 11 years, 25% female, 82% NYHA class I-II) were analysed. One year adherence to weight transmissions was 74%. Patients adherent to weight transmissions were less often hospitalized for HF in the six months before enrolment in the study than those non-adherent (8% vs. 23%, p=0.021). The percentage of patients visiting the PHR dropped steadily over time (93% versus 39% at one year). With univariable analyses there was no significant correlation between patient characteristics and adherence to weight transmissions. CONCLUSIONS Adherence to RPM was high among stable HF patients, and best for weighing, however, with adherence decreasing over time. Clinical and demographic variables seem not related to adherence to transmitting weight. CLINICALTRIAL NCT01755988.
No takes yet. Share an insight, caveat, or question.
Brons et al. (2022) conducted an observational in Stable heart failure (n=150). e-Vita HF telemonitoring platform vs. Non-adherent patients was evaluated on One year adherence to weight transmissions (≥ 3 times/week for at least 42 weeks). One year adherence to weight transmissions using the e-Vita HF telemonitoring platform was 74%, with adherent patients having fewer prior heart failure hospitalizations (8% vs. 23%, p=0.021).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: